Total Valuation
Manhattan Scientifics has a market cap or net worth of $559.00. The enterprise value is $4.19K.
Market Cap$559.00
Enterprise Value$4.19K
Share Statistics
Manhattan Scientifics has 559,281,070 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding559,281,070
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Manhattan Scientifics’s return on equity (ROE) is 0.65 and return on invested capital (ROIC) is 40.36%.
Return on Equity (ROE)0.65
Return on Assets (ROA)-3.69
Return on Invested Capital (ROIC)40.36%
Return on Capital Employed (ROCE)0.39
Revenue Per Employee0.00
Profits Per Employee-1.17M
Employee Count1
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Manhattan Scientifics is ―. Manhattan Scientifics’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00
PB Ratio-0.81
Price to Fair Value-0.81
Price to FCF-7.65
Price to Operating Cash Flow-0.29
PEG Ratio0.02
Income Statement
In the last 12 months, Manhattan Scientifics had revenue of 0.00 and earned -1.17M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit-1.00K
Operating Income-703.00K
Pretax Income-1.17M
Net Income-1.17M
EBITDA-1.16M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -110.00K and capital expenditures 0.00, giving a free cash flow of -110.00K billion.
Operating Cash Flow-110.00K
Free Cash Flow-110.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
Manhattan Scientifics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta17.31
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Manhattan Scientifics upcoming earnings date is May 15, 2018, During Market Hours (Confirmed).
Last Earnings DateInvalid Date
Next Earnings DateMay 15, 2018
Ex-Dividend Date―
Financial Position
Manhattan Scientifics as a current ratio of 0.03, with Debt / Equity ratio of -3.33%
Current Ratio0.03
Quick Ratio0.03
Debt to Market Cap0.04
Net Debt to EBITDA<0.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Manhattan Scientifics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Manhattan Scientifics EV to EBITDA ratio is -1.24, with an EV/FCF ratio of -7.62.
EV to Sales0.00
EV to EBITDA-1.24
EV to Free Cash Flow-7.62
EV to Operating Cash Flow-7.62
Balance Sheet
Manhattan Scientifics has $38.00K in cash and marketable securities with $60.00K in debt, giving a net cash position of -$22.00K billion.
Cash & Marketable Securities$38.00K
Total Debt$60.00K
Net Cash-$22.00K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Manhattan Scientifics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―